GRAHAM K. COOPER - 10 Jun 2021 Form 4 Insider Report for Beam Therapeutics Inc. (BEAM)

Role
Director
Signature
By: Christine Bellon, Attorney-in-fact
Issuer symbol
BEAM
Transactions as of
10 Jun 2021
Net transactions value
$0
Form type
4
Filing time
14 Jun 2021, 07:52:44 UTC
Previous filing
20 May 2021
Next filing
28 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BEAM Stock Option (Right to Buy) Award $0 +6,877 $0.000000 6,877 10 Jun 2021 Common Stock 6,877 $87.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the first anniversary of the date of grant, subject to the reporting person's continued service to the board of directors of Beam Therapeutics Inc. through the vesting date.